Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016

Drug Safety

Volumn 40, Issue 2, 2017, Pages 145-152

  Moro, Pedro ^a   Baumblatt, Jane ^b   Lewis, Paige ^a   Cragan, Janet ^c   Tepper, Naomi ^d   Cano, Maria ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE; LIVE VACCINE;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; ALLERGIC REACTION; APLASIA; ARTICLE; AUTISM; BELL PALSY; CLEFT LIP; CLEFT PALATE; COMMON COLD; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ECTOPIC KIDNEY; FEMALE; FETUS DEATH; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL DISEASE; GESTATIONAL AGE; GUILLAIN BARRE SYNDROME; HEADACHE; HEART VENTRICLE SEPTUM DEFECT; HEMOPHILIA A; HUMAN; HYDRONEPHROSIS; IMMUNOPATHOLOGY; INFECTION; INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; INJECTION SITE REACTION; INTRAUTERINE GROWTH RETARDATION; JAUNDICE; LARYNGOMALACIA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUSCULOSKELETAL DISEASE; MYELITIS; NEOPLASM; NEUROLOGIC DISEASE; NEWBORN DEATH; NEWBORN HYPOXIA; NOSE OBSTRUCTION; PATENT FORAMEN OVALE; POLYDACTYLY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PYELECTASIS; SEASONAL INFLUENZA; SECOND TRIMESTER PREGNANCY; SKIN APLASIA; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; THORAX PAIN; TRISOMY 18; VACCINE FAILURE; VAGINA BLEEDING; ADOLESCENT; CHILD; COMPARATIVE STUDY; DRUG SURVEILLANCE PROGRAM; INFANT; INFLUENZA; MIDDLE AGED; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; SEASON; YOUNG ADULT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; SEASONS; VACCINES, ATTENUATED; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 85006371305     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-016-0482-1     Document Type: Article

References (27)

1. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Novel Influenza A (H1N1) Pregnancy Working Group, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451–8.
2. Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-related mortality resulting from influenza in the United States during the 2009–2010 pandemic. Obstet Gynecol. 2015;126(3):486–90.
3. Skoronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine. 2009;27:4754–70.
4. Richards JL, Hansen C, Bredfeldt C, Bednarczyk RA, Steinhoff MC, Adjaye-Gbewonyo D, et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis. 2013;56(9):1216–22.
5. Shakib JH, Korgenski K, Presson AP, Sheng X, Varner MW, Pavia AT, et al. Influenza in infants born to women vaccinated during pregnancy. Pediatrics. 2016;137(6):e20152360.
6. Ding H, Santibanez TA, Jamieson DJ, Weinbaum CM, Euler GL, Grohskopf LA, et al. Influenza vaccination coverage among pregnant women–National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol. 2011;204(6 Suppl 1):S96–106.
7. Kharbanda EO, Vargas CY, Castaño PM, Lara M, Andres R, Stockwell MS. Exploring pregnant women’s views on influenza vaccination and educational text messages. Prev Med. 2011;52:75–7.
8. Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines. 2012;11(8):911–21.
9. Fell DB, Dodds L, MacDonald NE, Allen VM, McNeil S. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines. 2013;12(12):1417–30.
10. Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am J Obstet Gynecol 2011;204:146.e1–7.
11. Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011;205(5):473.e1–9.
12. Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398–405.
13. Medical Dictionary for Regulatory Activities. http://www.meddramsso.com/. Accessed 28 Apr 2011.
14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals. http://www.ich.org/products/meddra.html. Accessed 9 Aug 2016.
15. Cunningham G, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Williams obstetrics. New York: McGraw-Hill Companies, Inc.; 2010.
16. Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Fed Reg. 1997;62:52252–3.
17. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53:177–90.
18. Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25:381–92.
19. Martin D, Menschik D, Bryant-Genevier M, Ball R. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010–2011 seasonal influenza virus vaccine. Drug Saf. 2013;36(7):547–56.
20. Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374(9707):2115–22.
21. Hoffman KB1, Demakas AR, Dimbil M, Tatonetti NP, Erdman CB. Stimulated reporting: the impact of US Food and Drug Administration-issued alerts on the adverse event reporting system (FAERS). Drug Saf. 2014;37(11):971–80.
22. Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis. 2015;60(5):e11.
23. Regan AK, Moore HC, de Klerk N, Omer SB, Shellam G, Mak DB, et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis. 2016;62(10):1221–7.
24. Wortman AC, Casey BM, McIntire DD, Sheffield JS. Association of influenza vaccination on decreased stillbirth rate. Am J Perinatol. 2015;32(6):571–6.
25. Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects–Atlanta, Georgia, 1978–2005. MMWR Morb Mortal Wkly Rep. 2008;57(1):1–5. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a2.htm. Accessed 7 Aug 2016.
26. Phadke VK, Omer SB. Maternal vaccination for the prevention of influenza: current status and hopes for the future. Expert Rev Vaccines. 2016;22:1–26.
27. Centers for Disease Control and Prevention. Pregnant women and flu vaccination, Internet Panel Survey, United States, November 2015. http://www.cdc.gov/flu/fluvaxview/pregnant-women-nov2015.htm. Accessed 9 Aug 2016.